Format

Send to

Choose Destination
J Comp Eff Res. 2019 May;8(7):475-486. doi: 10.2217/cer-2018-0125. Epub 2019 Mar 29.

Treatment of gynecological malignancies: long-term follow-up of health-related quality of life and healthcare costs.

Author information

1
Department of Obstetrics & Gynecology, University of Helsinki & Helsinki University Hospital, PO Box 140 FI-00029 HUS, Finland.
2
University of Helsinki, Biomedicum, Haartmaninkatu 8, 00290 Helsinki, Finland.
3
University of Helsinki & Helsinki University Hospital, Administration, PO Box 705 FI-00029 HUS, Finland.
4
Department of Public Health, University of Helsinki, PO Box 41, FI-00014 University of Helsinki, Finland.
5
University of Helsinki & Helsinki University Hospital, Administration, PO Box 705 FI-00029 HUS, Finland & University of Eastern Finland, Kuopio, Finland.
6
External Evaluation Unit, University of Helsinki & Helsinki University Hospital, PO Box 440 FI-00029 HUS, Finland.

Abstract

Aim: To assess long-term health-related quality of life (HRQoL) and treatment-related costs in gynecological cancer patients, and to compare HRQoL between cancer types and to age-standardized general female population. Materials & methods: A prospective 8-10-year follow-up of 218 patients treated in Helsinki University Hospital in 2002-2004. Results: The most common malignancies were uterine, ovarian and cervical cancers. The mean HRQoL scores were 0.880 (baseline), 0.885 (6 months) and 0.884 for survivors in the end of the study. Depression, vitality and sexual activity were impaired at baseline but improved during follow-up. Total secondary healthcare costs during the follow-up averaged EUR 41342. Conclusion: The long-term HRQoL of surviving gynecological cancer patients was good and similar to that of age-standardized general female population.

KEYWORDS:

cancer; costs; gynecology; health-related quality of life; treatment

PMID:
30922069
DOI:
10.2217/cer-2018-0125

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center